VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
VaxCT
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Pathogen Page
Cancer

Table of Contents

  1. General Information
    1. Disease
    2. Introduction
  2. Vaccine Related Pathogen Genes
    1. 7299
    2. AAV2gp02 (Adeno-associated virus - 2)
    3. ABALON (Homo sapiens)
    4. ABL2 (Homo sapiens)
    5. ACP3 (Homo sapiens)
    6. ACPP (Homo sapiens)
    7. ADAM17 (Homo sapiens)
    8. AFP (Homo sapiens)
    9. AFP from human-Obsolete (Homo sapiens)
    10. ag85A (Mycobacterium tuberculosis H37Rv)
    11. AIM2 (Homo sapiens)
    12. AKAP4 (Homo sapiens)
    13. AKT1 (Homo sapiens)
    14. ALDH1A1 (Homo sapiens)
    15. ALDH2 (Homo sapiens)
    16. ANTXR1 (Homo sapiens)
    17. AR (Homo sapiens)
    18. asdfaf asf
    19. ASTE1 (Homo sapiens)
    20. ATL1 (Homo sapiens)
    21. B4GALNT1 (Homo sapiens)
    22. BCAP31 (Homo sapiens)
    23. BCL2L1 (Homo sapiens)
    24. CA9 (Homo sapiens)
    25. CCL21 (Homo sapiens)
    26. Ccl21a (Mus musculus)
    27. CCNG1 (Homo sapiens)
    28. CCNI (Homo sapiens)
    29. CCR5 (Homo sapiens)
    30. CCR7 (Homo sapiens)
    31. CD19 (Homo sapiens)
    32. CD1D (Homo sapiens)
    33. CD22 (Homo sapiens)
    34. CD33 (Homo sapiens)
    35. CD38 (Homo sapiens)
    36. CD3D (Homo sapiens)
    37. CD40 (Homo sapiens)
    38. Cd40lg (Mus musculus)
    39. CD40LG (Homo sapiens)
    40. CD44 (Homo sapiens)
    41. CD55 (Homo sapiens)
    42. CD58 (Homo sapiens)
    43. CD70 (Homo sapiens)
    44. Cd80 (Mus musculus)
    45. CD80 (Homo sapiens)
    46. Cd86 (Mus musculus)
    47. CD86 (Homo sapiens)
    48. CD8A (Homo sapiens)
    49. CD90 (Homo sapiens)
    50. CDH3 (Homo sapiens)
    51. CDK1 (Homo sapiens)
    52. cdsR (Chlamydia trachomatis A/HAR-13)
    53. Cea-Mouse (Mus musculus)
    54. CEACAM1 (Homo sapiens)
    55. CEACAM3 (Homo sapiens)
    56. CEACAM5 (CEA) (Homo sapiens)
    57. CEACAM5 - obsolete (Homo sapiens)
    58. CHI3L1 (Homo sapiens)
    59. CLEC3B (Homo sapiens)
    60. CLEC4C (Homo sapiens)
    61. CRY2 (Arabidopsis thaliana)
    62. CSF1R (Homo sapiens)
    63. Csf2-Mouse (Mus musculus)
    64. CSH1 (Homo sapiens)
    65. CTAG1B (Homo sapiens)
    66. CTAG2 (Homo sapiens)
    67. CTLA4 (Homo sapiens)
    68. cupB5 (Pseudomonas aeruginosa PAO1)
    69. CYP1B1 (Homo sapiens)
    70. DCT (Homo sapiens)
    71. DCT (Homo sapiens)
    72. DDR1 (Homo sapiens)
    73. DEPDC1 (Homo sapiens)
    74. DItox
    75. E1B (Human mastadenovirus C)
    76. E2A (Mus musculus)
    77. E6 (Human papillomavirus type 16)
    78. E7 (Human papillomavirus type 16)
    79. EBNA-1 (Human gammaherpesvirus 4)
    80. EGFR (Homo sapiens)
    81. Emb (Mus musculus)
    82. Eng (Mus musculus)
    83. ENG (Homo sapiens)
    84. env (Human immunodeficiency virus 1)
    85. EPCAM (Homo sapiens)
    86. EPHA2 (Homo sapiens)
    87. ERBB2 (Homo sapiens)
    88. Erbb2 (Rattus norvegicus)
    89. EWSR1 (Homo sapiens)
    90. Fasl (Mus musculus)
    91. FASLG (Homo sapiens)
    92. FCY1 (Saccharomyces cerevisiae S288C)
    93. FGF2 (Homo sapiens)
    94. FGF5 (Homo sapiens)
    95. FIM3 (Homo sapiens)
    96. FL1 (Homo sapiens)
    97. FLT1 (Homo sapiens)
    98. Flt3 (Mus musculus)
    99. FLT3LG (Homo sapiens)
    100. FOLH1 (Homo sapiens)
    101. FOLR1 (Homo sapiens)
    102. Fosl1 (Mus musculus)
    103. FOXO1 (Homo sapiens)
    104. Fragment C from tetanus toxin (Clostridium tetani)
    105. FUS (Homo sapiens)
    106. GAA (Homo sapiens)
    107. GALC (Homo sapiens)
    108. Gla (Mus musculus)
    109. GLIPR1 (Homo sapiens)
    110. GM-CSF (Papio anubis)
    111. GM-CSF (human) (Homo sapiens)
    112. GM-CSF (Mus musculus) (Mus musculus)
    113. GM2A (Homo sapiens)
    114. GNRH1 (Homo sapiens)
    115. Gnrh1 (Mus musculus)
    116. gp100 (PMEL) (Homo sapiens)
    117. gp160
    118. gp72 (Human herpesvirus 4 type 2)
    119. GPC3 (Homo sapiens)
    120. GPR183 (Homo sapiens)
    121. GPT (Homo sapiens)
    122. GRDX (Homo sapiens)
    123. GRIN1 (Homo sapiens)
    124. GRP (Homo sapiens)
    125. GUCY2C (Homo sapiens)
    126. H2-K1 (Mus musculus)
    127. HA (Influenza A virus (A/California/07/2009(H1N1)))
    128. HBB (Homo sapiens)
    129. HBsAg (Hepatitis B virus)
    130. HER2-Dupli
    131. HLA-A (Homo sapiens)
    132. HLA-B (Homo sapiens)
    133. HLA-DRB1 (Homo sapiens)
    134. HPV6 E6 (Human papillomavirus type 6)
    135. HPV6 E6 (Human papillomavirus type 6)
    136. HRAS (Homo sapiens)
    137. HSP47 (Mus musculus)
    138. HSP90B1 (Homo sapiens)
    139. HSPA4 (Homo sapiens)
    140. HSPD1 (Homo sapiens)
    141. HuD (Homo sapiens)
    142. human TP53 (P53) (Homo sapiens)
    143. HUMGP 75 (Homo sapiens)
    144. ICAM1 (Homo sapiens)
    145. ID1 (Homo sapiens)
    146. IDH1 (Homo sapiens)
    147. IDO1 (Homo sapiens)
    148. IFNA2 (Homo sapiens)
    149. IFNB1 (Homo sapiens)
    150. IFNG (Homo sapiens)
    151. IFNG- Obsolete (Homo sapiens)
    152. IFNL3 (Homo sapiens)
    153. IGF2BP3 (Homo sapiens)
    154. IGFBP1 (Homo sapiens)
    155. IgG Fc (Homo sapiens)
    156. IGHG1 (Homo sapiens)
    157. IL12 (Sus scrofa)
    158. IL12A (Homo sapiens)
    159. IL12B (Homo sapiens)
    160. IL13RA2 (Homo sapiens)
    161. Il18 (Mus musculus)
    162. IL2 (Homo sapiens)
    163. IL2-Duplicate (Homo sapiens)
    164. IL24 (Homo sapiens)
    165. IL3RA (Homo sapiens)
    166. Immunoglobulin (Homo sapiens)
    167. ITGB8 (Homo sapiens)
    168. ITIH4 (Homo sapiens)
    169. JUP (Homo sapiens)
    170. KDR (Homo sapiens)
    171. Kdr (Mus musculus)
    172. KIF20B (Homo sapiens)
    173. KLK3 (Homo sapiens)
    174. KLK3-Dupli (Homo sapiens)
    175. KRAS (Homo sapiens)
    176. KRAS (Homo sapiens)
    177. L1 (Human papillomavirus)
    178. lacZ (Escherichia coli str. K-12 substr. MG1655)
    179. LADD-Ag
    180. LILRA2 (Homo sapiens)
    181. LMP-1 (Human gammaherpesvirus 4)
    182. LMP-2A (Human gammaherpesvirus 4)
    183. LV28_RS26095 transcriptional regulator RegF (Pandoraea pnomenusa)
    184. LY6K (Homo sapiens)
    185. MAGE-1 (Homo sapiens)
    186. MAGEA1 (MAGE1) (Homo sapiens)
    187. MAGEA1-Duplicate
    188. MAGEA10 (Homo sapiens)
    189. MAGEA2 (Homo sapiens)
    190. MAGEA3 (Homo sapiens)
    191. MAGEA6 (Homo sapiens)
    192. MAGEA9 (Homo sapiens)
    193. MAGEC1 (Homo sapiens)
    194. MAGEC2 (Homo sapiens)
    195. major capsid protein L1
    196. MBL2 (Homo sapiens)
    197. Mcam (Mus musculus)
    198. MDM2 (Homo sapiens)
    199. MFGE8 (Homo sapiens)
    200. MGMT (Homo sapiens)
    201. Mice Gene
    202. MLANA (Homo sapiens)
    203. MLANA-Dupli (Homo sapiens)
    204. mouse Trp53 (Mus musculus)
    205. MOV10 (Homo sapiens)
    206. MS4A1 (Homo sapiens)
    207. MSLN (Homo sapiens)
    208. MUC1 (Homo sapiens)
    209. Muc1 (Mus musculus)
    210. MUC16 (Homo sapiens)
    211. MUC2 (Homo sapiens)
    212. MUC5B (Homo sapiens)
    213. NF2 (Homo sapiens)
    214. NRAS (Homo sapiens)
    215. NRP1 (Homo sapiens)
    216. NSCLC
    217. NUF2 (Homo sapiens)
    218. NY-ESO-1 (Homo sapiens)
    219. ny-eso-1
    220. ORF68 (Human alphaherpesvirus 3)
    221. P10
    222. PAEP (Homo sapiens)
    223. PAGR1 (Homo sapiens)
    224. PAP (Mus musculus)
    225. Pap antigen (Homo sapiens)
    226. PAX3 (Homo sapiens)
    227. PDCD1 (Homo sapiens)
    228. Pdgfrb (Mus musculus)
    229. PMEL - OBSOLETE (Homo sapiens)
    230. PMEL - obsolete (Homo sapiens)
    231. Pmel17 (Mus musculus)
    232. pp65 (Mus musculus)
    233. PRAME (Homo sapiens)
    234. Prn (Mus musculus)
    235. PROM1 (Homo sapiens)
    236. Prostate specific antigen (Mus musculus)
    237. Prostate stem cell antigen (Mus musculus)
    238. Prostate-specific membrane antigen (Homo sapiens)
    239. Prostate-specific membrane antigen (Rattus norvegicus)
    240. PSMB9 (Homo sapiens)
    241. PTPRC (Homo sapiens)
    242. PTTG1 (Homo sapiens)
    243. RANBP2 (Homo sapiens)
    244. RHD (Homo sapiens)
    245. RNF43 (Homo sapiens)
    246. ROPN1 (Homo sapiens)
    247. Rpsa (Mus musculus)
    248. RUNX1 (Homo sapiens)
    249. S (Hepatitis B virus)
    250. S100A6 (Homo sapiens)
    251. S100A9 (Homo sapiens)
    252. SCFV (Homo sapiens)
    253. SCGB2A2 (Homo sapiens)
    254. SDC1 (Homo sapiens)
    255. SDC1-Obsolete (Homo sapiens)
    256. sialyl-Tn
    257. SILV (Homo sapiens)
    258. SLAMF7 (Homo sapiens)
    259. SLC5A5 (Homo sapiens)
    260. SOX2 (Homo sapiens)
    261. SOX6 (Homo sapiens)
    262. SPA17 (Homo sapiens)
    263. SPANXB1 (Homo sapiens)
    264. SPBC17D11.03c hypothetical protein (Schizosaccharomyces pombe)
    265. SPY-1
    266. ST8SIA1 (Homo sapiens)
    267. Steap1 (Mus musculus)
    268. STEAP1 (Homo sapiens)
    269. Survivin (Homo sapiens)
    270. Survivin (Mus musculus)
    271. TAF1B (Homo sapiens)
    272. TARP (Homo sapiens)
    273. TBXT (Homo sapiens)
    274. TERT (Homo sapiens)
    275. TET1 (Homo sapiens)
    276. tetX (Clostridium tetani E88)
    277. TF (Homo sapiens)
    278. TGFB2 (Homo sapiens)
    279. Th (Mus musculus)
    280. TLR4 (Homo sapiens)
    281. TLR7 (Homo sapiens)
    282. TLR9 (Homo sapiens)
    283. TMEM37 (Homo sapiens)
    284. TNF (Homo sapiens)
    285. tnf-alpha (Oncorhynchus mykiss)
    286. TNFRSF18 (Homo sapiens)
    287. TNFSF10 (Homo sapiens)
    288. TNFSF18 (Homo sapiens)
    289. TOMM34 (Homo sapiens)
    290. TOP2A (Homo sapiens)
    291. tox1 (Corynebacterium diphtheriae PW8)
    292. TP53 - delete (Homo sapiens)
    293. TPBG (Homo sapiens)
    294. TRP-1 (Mus musculus)
    295. TRP-2 (Homo sapiens)
    296. Trp2 (Mus musculus)
    297. TRPC1 (Homo sapiens)
    298. Tumor Associated Antigen
    299. Tyrosinase (Homo sapiens)
    300. Tyrosinase from Mouse (Mus musculus)
    301. TYRP1 (Homo sapiens)
    302. Tyrp1 (Mus musculus)
    303. Ubiquitin (Mus musculus)
    304. UL122 (Human betaherpesvirus 5)
    305. UL123 (Human betaherpesvirus 5)
    306. UL83 (Human betaherpesvirus 5)
    307. UL83 (Human betaherpesvirus 5)
    308. UL97
    309. VEGFA (Homo sapiens)
    310. VHL (Homo sapiens)
    311. WHcAg (Woodchuck hepatitis virus)
    312. WT1 (Homo sapiens)
    313. Xbp1 (Mus musculus)
    314. XBP1 (Homo sapiens)
    315. Xcl1 (Mus musculus)
    316. XCL1 (Homo sapiens)
    317. YBX1 (Homo sapiens)
  3. Vaccine Information
    1. (H115D)VHL35 Peptide Vaccine
    2. 1(SOCS1)-silenced dentritic cell (DC) vaccines
    3. 117-126:FGF-5 Peptide
    4. 12MP
    5. 12MP, 12MP/Tet, 12MP/6MHP, or 6MHP
    6. 27-35(27L):MART-1 peptide vaccine
    7. 4-peptide melanoma vaccine
    8. 851B Gel
    9. A2/4-1BBL melanoma vaccine
    10. Abagovomab
    11. Ad CMV I kappaB alpha
    12. Ad-sig-hMUC-1/ecdCD40L Vaccine
    13. Ad5-yCD/mutTKSR39rep-hIL12
    14. Ad5F35-LMP1/LMP2-Transduced Autologous Dendritic Cells
    15. Adenovector Encoding MDA7
    16. Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201
    17. Adenoviral Vector Ad5-CEA(6D) Vaccine
    18. Adenovirus 5-CD40 Ligand
    19. Adenovirus 5-Fibroblast Growth Factor 2
    20. Adenovirus 5-Human Guanylyl Cyclase C-PADRE Vaccine
    21. Adenovirus B7-1
    22. Adenovirus Encoding Rat HER-2/neu
    23. Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine
    24. Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine
    25. Adenovirus RSV-TK
    26. Adenovirus-mediated Human Interleukin-12
    27. Adenovirus-p53 Transduced Dendritic Cell Vaccine
    28. Adenovirus-PSA Prostate Cancer Vaccine
    29. adenovirus-transfected autologous DC vaccine plus CIK cells
    30. Adenovirus-vectored therapeutic vaccine (Ad-Ii-E1E2E6E7)
    31. AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine
    32. AE37 Peptide/GM-CSF Vaccine
    33. AFP Gene Hepatocellular Carcinoma Vaccine
    34. Ag NY-ESO-1
    35. AGS-003-BLD Vaccine
    36. AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
    37. Algenpantucel-L
    38. ALK peptide vaccine
    39. Allogeneic AML Antigen-expressing Dendritic Cell Vaccine
    40. Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine
    41. Allogeneic Cellular Vaccine 1650-G
    42. Allogeneic Dendritic Cell Vaccine COMBIG-DC
    43. Allogeneic Dendritic Cell-Myeloma Idiotype Vaccine
    44. Allogeneic Glioblastoma Stem-like Cell Line Lysate-pulsed Autologous Dendritic Cell Vaccine
    45. Allogeneic GM-CSF-Based Myeloma Cell Vaccine
    46. Allogeneic GM-CSF-Secreting Breast Cancer Vaccine
    47. Allogeneic GM-CSF-secreting Lethally Irradiated Pancreatic Tumor Cell Vaccine
    48. Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo
    49. Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo
    50. Allogeneic HLA-A2/4-1BB ligand-expressing Melanoma Vaccine
    51. Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
    52. Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307
    53. Allogeneic Melanoma Vaccine AGI-101H
    54. Allogeneic Mesothelioma Tumor Lysate-pulsed Autologous Dendritic Cell Vaccine
    55. Allogeneic Multipotent Adult Progenitor Cells
    56. Allogeneic Renal Cell Carcinoma Vaccine MGN1601
    57. Allogeneic Tumor Cell Vaccine
    58. Allogenic Glioma Cancer Vaccine
    59. Alpha Fetoprotein Adenoviral Vector Vaccine
    60. Alpha Fetoprotein Plasmid DNA Vaccine
    61. Alpha-1,3-galactosyltransferase-expressing Allogeneic Renal Cell Carcinoma Vaccine
    62. Alpha-fetoprotein Peptide-Pulsed Autologous Dendritic Cell Vaccine
    63. Alpha-Galactosylceramide-Pulsed Autologous Dendritic Cells
    64. Alpha-type-1 Polarized Dendritic Cells
    65. ALVAC gp100 Vaccine
    66. ALVAC Vaccine
    67. ALVAC(2) Melanoma Multi-antigen Vaccine
    68. ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
    69. ALVAC-B7-CEA
    70. ALVAC-CEA (6D)-B7.1 Vaccine
    71. ALVAC-CEA (VCP248)
    72. ALVAC-CEA B7.1 Vaccine
    73. ALVAC-CEA Vaccine
    74. ALVAC-ESO-1 Vaccine
    75. ALVAC-hB7.1
    76. ALVAC-MART-1 Vaccine
    77. ALVAC-P53 Vaccine
    78. AMHR2-ED
    79. AML mRNA Positive Lysate Loaded Autologous Dendritic Cell Vaccine
    80. Amolimogene Bepiplasmid
    81. Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118
    82. Ankara (MVA) and ALVAC(2) Vaccine
    83. Ankara (MVA) Vaccine
    84. Anti-CD19/CD3 Tetravalent Antibody AFM11 Vaccine
    85. Anti-CD3 x Anti-CD20 Bispecific Antibody-Armed Activated T Cells Cancer Vaccine
    86. Anti-CEA TCR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes
    87. Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine
    88. Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine
    89. Anti-GnRH Vaccine PEP223
    90. Anti-HER2/HER3 Dendritic Cell Vaccine
    91. Anti-idiotype MUC-1 Monoclonal Antibody Vaccine
    92. Anti-Idiotype Specified Monoclonal Antibody
    93. anti-idiotypic (anti-id) mAb MK2-23 + BCG
    94. Anti-idiotypic Monoclonal Antibody BEC2 Vaccine
    95. Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
    96. Anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes
    97. Anti-p53 T-Cell Receptor-Transduced Peripheral Blood Lymphocytes Vaccine
    98. Anti-PRAME Immunotherapeutic GSK2302032A Vaccine
    99. Antigen-CPP vaccine
    100. Antigen-targeted Personalized Breast Cancer Vaccine
    101. APC8015F
    102. Apoptotic Autologous Tumor Cells-pulsed Alpha-type-1 Polarized Dendritic Cells
    103. attenuated Listeria expressing cancer antigen vaccine
    104. AUT-OV-ALVAC-hB7.1 Vaccine
    105. Autolgous DC Vaccine Pulsed with Autologous Tumor Homogenate for Metastatic RCC
    106. Autologous Ad-CD154-Transduced CLL B Cells
    107. Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
    108. Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
    109. Autologous Cancer Testis Antigen Specific Dendritic Cell Vaccine
    110. Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine
    111. Autologous CD40L-expressing B-CLL Vaccine
    112. Autologous CLL Tumor Cell Vaccine
    113. Autologous CMV-pp65-flLAMP mRNA Loaded Dendritic Cell Vaccine
    114. Autologous Colorectal Tumor Antigen-pulsed Dendritic Cell Vaccine
    115. Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells
    116. autologous dendritic cell vaccine (DCV)
    117. Autologous Dendritic Cell Vaccine ACT2001
    118. Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
    119. Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
    120. Autologous Dendritic Cell-Adenovirus P53 Vaccine
    121. Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine
    122. Autologous Dendritic Cell-Autologous Tumor mRNA-Human CD40L Vaccine
    123. Autologous Dendritic Cell-based Immunotherapeutic AV0113
    124. Autologous Dendritic Cell-Tumor Fusion Vaccine
    125. autologous dendritic cells (DCs)
    126. Autologous Dinitrophenyl Vaccine
    127. Autologous Dinitrophenyl-Modified Ovarian Cancer Vaccine
    128. Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine
    129. Autologous Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Vaccine
    130. Autologous Expanded Mesenchymal Stem Cells OTI-010
    131. Autologous GM-CSF-Secreting Breast Cancer Vaccine
    132. Autologous GM-CSF-secreting Lethally Irradiated Colorectal Cancer Cell Vaccine
    133. Autologous GM-CSF-Secreting Lethally Irradiated Leukemia Cell Vaccine
    134. Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858
    135. Autologous HNSCC DNA-transfected Semi-allogeneic Fibroblasts MRC-5 Vaccine
    136. Autologous IL-2-expressing B-CLL Vaccine
    137. Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine
    138. Autologous Lymphoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine
    139. Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
    140. Autologous Lymphoma Cell/Autologous Dendritic Cell Electrofusion Hybrid Vaccine
    141. Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine
    142. Autologous Melanoma Lysate-Pulsed Autologous Dendritic Cell Vaccine
    143. Autologous Melanoma Lysate/KLH-Pulsed Autologous Dendritic Cell Vaccine
    144. Autologous Melanoma Lysate/NY-ESO-1-pulsed Autologous Dendritic Cell Vaccine
    145. Autologous monocyte-derived mature DCs pulsed with p53, survivin and telomerase-derived peptides
    146. Autologous MUC1 peptide-pulsed DC vaccine
    147. Autologous Neuroblastoma Vaccine
    148. Autologous NSCLC DNA-Transfected Semi-Allogeneic Fibroblasts MRC-5 Vaccine
    149. Autologous NSCLC Peptide-specific Dendritic Cell Vaccine
    150. Autologous OFA-iLRP RNA-Transfected Dendritic Cell Vaccine
    151. Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine
    152. Autologous Oxidized Ovarian Tumor Cell Lysate Vaccine
    153. Autologous Pluripotent ALDHbr Stem Cells ALD-451
    154. Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101
    155. Autologous Renal Cell Carcinoma Tumor Lysate-Pulsed Dendritic Cell Vaccine
    156. Autologous Sarcoma Lysate-pulsed Dendritic Cell Vaccine
    157. Autologous TARP Peptide-Pulsed Dendritic Cell Vaccine
    158. Autologous Total Tumor mRNA and CMV-pp65-flLAMP mRNA Loaded Liposome Vaccine
    159. Autologous TriMix-DC Melanoma Vaccine
    160. Autologous tumor cell lysate vaccine
    161. Autologous Tumor Cell Proteoliposome Chronic Lymphocytic Leukemia Vaccine
    162. Autologous Tumor Cell Vaccine
    163. Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
    164. Autologous, DNP-Modified Ovarian Cancer Vaccine
    165. Autologous-Cell Leukemia Vaccine
    166. Autologous-Cell Melanoma Vaccine
    167. B-cell lymphoma DNA vaccine VCL-1642.XXX encoding a chimeric immunoglobulin molecule onsisting of tumor-specific variable (Id) regions
    168. B16 melanoma DNA vaccine pCMV-hTRP-1 encoding TRP-1
    169. B16 melanoma DNA vaccine pSin-hTRP-1 encoding TRP-1
    170. B16 melanoma DNA vaccine pSin-mTRP-1
    171. B16 Vaccine adjuvanted by Loxoribine
    172. B7.1/​IL-2 Leukaemia Cell Vaccine
    173. Bacille Calmette Guérin for melanoma of lower extremity
    174. Bacillus Calmette-Guerin (BCG)
    175. Bacillus Calmette-Guerin (BCG), C. parvum
    176. Bacillus Calmette-Guerin (BCG), dinitrochlorobenzene (DNCB)
    177. bacillus Calmette-Guerin (MER)
    178. BC-819
    179. BCG
    180. BCG and chemotherapy for malignant melanoma
    181. BCG and Corynebacterium parvum for malignant melanoma
    182. BCG treatment after surgical tumor removal
    183. BCG, Cell Wall Skeleton
    184. Bcl-Xl_42-CAF09b Vaccine
    185. Bcl-Xs Adenovirus Vaccine
    186. Bcr-Abl (b2a2)-Derived Peptide Vaccine
    187. Bcr-Abl (b3a2)-Derived Peptide Vaccine
    188. Bcr-abl peptide vaccine
    189. Belagenpumatucel-L
    190. Berzofsky Ras/P53 Peptide Vaccine
    191. Biolistic DNA vaccination
    192. Bivalent Vaccine with Adjuvant OPT-821
    193. Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine
    194. Brain Tumor Initiating Cell Vaccine
    195. C29561
    196. Canarypox-hIL-12 Melanoma Vaccine
    197. Cancer DNA Vaccine encoding Endoglin Boosted with Recombinant Endoglin Protein
    198. Cancer DNA Vaccine encoding TEM8
    199. Cancer DNA Vaccine MIDGE/hNIS encoding hNIS protein
    200. Cancer DNA vaccine p.DOM-AH1 encoding fragment C
    201. Cancer DNA Vaccine pLXSHDmB7-2 encoding Cd86
    202. Cancer DNA Vaccine pSURV encoding Survivin
    203. Cancer EPCAM protein vaccine
    204. Cancer Her-2/neu Protein Subunit Vaccine
    205. Cancer recombinant vector vaccine encoding H-2Kb
    206. Cancer Retroviral Vector Vaccine encoding Cd40lg
    207. Cancer Stem Cell DC Vaccine
    208. Cancer Subunit DC (Tat-CEA) vaccine
    209. Cancer Subunit GV1001 Protein Vaccine
    210. Cancer Subunit NY-ESO-1 Protein Vaccine
    211. Cancer Vaccine using E7 protein of human papillomavirus 16 and Algammulin
    212. Cancer Vaccine using E7 protein of human papillomavirus 16 and Quil-A
    213. Cancer VEGFA protein vaccine
    214. Canvaxin
    215. CAP-2 (CEA Peptide 9-mer)
    216. CAP-3 (CEA Peptide 9-mer)
    217. CAR G36-PDL1
    218. Carcinoembryonic Antigen Peptide 1-6D
    219. Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine
    220. Carcinoembryonic Antigen Peptide-1 Vaccine
    221. Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine
    222. Carcinoma DNA vaccine pVAX/E2A
    223. CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
    224. CD133 Antigen Peptide-pulsed Autologous Dendritic Cell Vaccine
    225. CD80 Breast Cancer Vaccine
    226. CDX-1307 Vaccine
    227. CEA RNA-pulsed Autologous Human Cultured Dendritic Cells
    228. CEA/Tetanus Toxoid T Helper Epitope Fusion Protein-Expressing DNA Plasmid Vaccine
    229. Chimeric Ad11p/Ad3 Oncolytic Virus
    230. Chimeric exosomal tumor vaccine
    231. Class I HLA-A*0201-restricted gp100209-2M peptide vaccine
    232. CLL Idiotypic DNA Vaccine
    233. CMV pp65 Peptide-pulsed Autologous Dendritic Cell Vaccine
    234. CMVpp65/gB Plasmid Vaccine ASP0113
    235. Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen
    236. Contusugene ladenovec
    237. Corynebacterium parvum, DTIC
    238. CpG 7909/PF3512676
    239. CTP-37-DT Vaccine
    240. CVB4/p24(73(3))
    241. Cyclin B1 Peptide-pulsed Autologous Dendritic Cell Vaccine
    242. Cyclin B1/WT-1/CEF-Loaded DC Vaccine
    243. Cytokine-Induced Killer Cells
    244. DC/AML Fusion Vaccine
    245. Dendritic Cell Survivin Vaccine
    246. Dendritic Cell Tumor Cell Lysate Vaccine
    247. Dendritic Cell Tumor Peptide Vaccine
    248. Dendritic Cell-Autologous Lung Tumor Vaccine
    249. Dendritic Cell-CEA Peptide Vaccine
    250. Dendritic Cell-gp100-MART-1 Antigen Vaccine
    251. Dendritic Cell-Idiotype-Keyhole Limpet Hemocyanin Vaccine
    252. Dendritic Cell-MART-1 Peptide Vaccine
    253. Dendritic Cell-Recombinant Prostate-Specific Membrane Antigen Vaccine
    254. Dendritic Cell-targeting Lentiviral Vector ID-LV305
    255. Dendritic Cell/​Myeloma Fusion Vaccine
    256. Dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes
    257. Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes
    258. DEPDC1/MPHOSH1 Peptide Vaccine
    259. Dinitrophenyl-Modified Autologous Renal Cell Carcinoma Tumor cell Vaccine
    260. DIPG and GMB Immunomodulatory DC Vaccine
    261. DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
    262. DNA Plasmid Encoding Interleukin-12 INO-9012
    263. DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112
    264. DNA Vaccine encoding p42.3
    265. DNA Vaccine VB10.16
    266. DNA Vector pPRA-PSM Vaccine
    267. DNP-modified autologous vaccine
    268. E1M(184V) Peptide Vaccine
    269. EF-1 Peptide Vaccine
    270. EF-2 Peptide Vaccine
    271. EGFRvIII Peptide Vaccine
    272. Electrofusion DC vaccine
    273. electroloading of mature dendritic cells with melanoma whole tumor cell lysate
    274. Emepepimut-S Vaccine
    275. EP-2101 Vaccine
    276. ESAT-6-gpi DNA vaccine combined with B16F10-ESAT-6-gpi/IL-21 vaccine
    277. ESO-1 (161-180) Peptide Vaccine
    278. ESO-1 Reactive Autologous Peripheral Blood Lymphocyte Vaccine
    279. ESO-1:157-165(165V) Peptide Vaccine
    280. ESR1 peptide vaccine
    281. Falimarev Vaccine
    282. Fas-Chimera Transgene-expressing Endothelial Tumor Cell-targeting Adenovector VB-111 Vaccine
    283. Flagrp170
    284. Folate-FITC Vaccine
    285. Follicular lymphoma, patient-specific, soluble protein idiotype vaccine
    286. Fowlpox Virus Vaccine
    287. Fowlpox Virus Vaccine Vector
    288. Fowlpox-NY-ESO-1 Vaccine
    289. Fowlpox-PSA-TRICOM Vaccine
    290. FRAME-001 personalized vaccine
    291. FrSh61 (MEA) VHL33 Peptide Vaccine
    292. FVAX
    293. G250 Peptide Vaccine
    294. Gag:267-274 Peptide Vaccine
    295. GD2-CAR
    296. GD2L, GD3L, Globo H, fucosyl GM1, and N-propionylated polysialic acid KLH Conjugate Vaccine
    297. Genetically Engineered Allogeneic Prostate Carinoma Cells Secreting Interleukin-2 and Interferon Gamma
    298. GITRL RNA-transfected Autologous Dendritic Cell Vaccine
    299. Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine
    300. Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701
    301. Globo H-DT Vaccine OBI-833
    302. Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine
    303. Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine
    304. Glypican-3-derived peptide vaccine for human hepatocellular carcinoma
    305. GM-CSF transfected cells vaccine
    306. GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccine
    307. GM-CSF-encoding Oncolytic Adenovirus CGTG-102 Vaccine
    308. GM-K562 cell vaccine
    309. GM.CD40L Cell Vaccine
    310. GM2/GD2/GD3 Lactone-KLH Conjugate Trivalent Vaccine
    311. Golnerminogene Pradenovec Vaccine
    312. gp100 + Mart-1 + Mart-3 Vaccine
    313. gp100 Adenovirus Vaccine
    314. gp100 and GM-CSF DNA/Gold Vaccine
    315. gp100 mature dendritic cell vaccine
    316. gp100 Protein (184V) Vaccine
    317. gp100 Vaccine
    318. gp100 Vaccinia Vaccine
    319. gp100-Fowlpox Vaccine
    320. gp100-Pulsed Peripheral Blood Mononuclear Cell Vaccine
    321. gp100-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
    322. gp100/IFA Vaccine
    323. gp100: ES209-217(210M) Peptide Vaccine
    324. gp100:154-162 Peptide Vaccine
    325. gp100:209-217 Peptide Vaccine
    326. gp100:209-217(210M) peptide vaccine
    327. gp100:280-288 Peptide Vaccine
    328. gp100:280-288(288V) Peptide Vaccine
    329. gp96-secreting Allogeneic Bladder Cancer Cell Vaccine HS-410
    330. GVAX Cancer Vaccine
    331. GVAX Leukemia Vaccine
    332. GVAX Lung Cancer Vaccine
    333. GVAX Pancreatic Cancer Vaccine
    334. H3.3K27M-specific Peptide Vaccine
    335. hapten dinitrophenyl
    336. HCA587 protein vaccine
    337. HCV DNA Vaccine INO-8000
    338. HER-2-neu, CEA peptides, GM-CSF, Montanide ISA-51 vaccine
    339. HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901
    340. HER2 ICD peptide vaccine
    341. HER2-pulsed Autologous Type-1 Polarized Dendritic Cell Vaccine
    342. Hexapeptide melanoma vaccine
    343. HLA Neoantigen Vaccine
    344. HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
    345. HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine
    346. HLA-A*0201-Restricted VEGFR1 Peptide Vaccine
    347. HLA-A*2402-Restricted VEGFR1 Peptide Vaccine
    348. HLA-A*2402-Restricted VEGFR1/2 Multipeptide Vaccine
    349. HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine
    350. HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine
    351. HLA-A1, HLA-A2, and CD40-Ligand Pulsed Dendritic Cell Vaccine
    352. HLA-A1-Binding MAGE-1/MAGE-3 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
    353. HLA-A2, A3-Restricted FGF-5 Peptides/Montanide ISA-51 Vaccine
    354. HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
    355. HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine
    356. HLA-Matched Donor Mononuclear Cell-Enriched Leukocytes Apocell Vaccine
    357. hMART-IT
    358. Hodgkin's antigens-GM-CSF-expressing cell vaccine
    359. Host Dendritic Cell Vaccine-001 MSSM/BIIR
    360. HPV 16 E6 (18-26) Peptide Vaccine
    361. HPV 16 E7:12-20 Peptide Vaccine
    362. HPV 16 E7:86-93 Peptide Vaccine
    363. HPV 16 L1-VLP Vaccine
    364. HPV 18 E6:13-21 Peptide Vaccine
    365. HPV 18 L1-VLP Vaccine
    366. HPV DNA Plasmids Therapeutic Vaccine VGX-3100
    367. HPV E6/E7 DNA Vaccine GX-188E
    368. HPV E6/E7-encoding Semliki Forest Virus Vaccine Vvax001
    369. HPV-11 Vaccine
    370. HPV-6-targeting Immunotherapeutic Vaccine INO-3106
    371. HPV16 E6/E7 Melanoma Vaccine
    372. HSP65-HER2 fusion peptide
    373. Hsp70 chaperone-based gel composition
    374. HSPPC-96
    375. hTERT I540/R572Y/D988Y Multipeptide Vaccine
    376. hTERT mRNA/Survivin Peptide-double-loaded Autologous Dendritic Cell Vaccine
    377. hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301
    378. hTERT Vaccine V934/V935
    379. hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1
    380. hTERT/Survivin/CMV Multipeptide Vaccine
    381. hTERT/Survivin/Melanoma Tumor Cell-Derived mRNA-Transfected Dendritic Cell Vaccine
    382. human leukocyte antigen class I-modified peptides
    383. Human Myeloid Progenitor Cells CLT-008 Vaccine
    384. Human Papilloma Virus L1 Virus-Like Particle V504 Vaccine
    385. Human Papillomavirus 16 E7 Peptide/Padre 965.10 Vaccine
    386. Human Papillomavirus 16/18 L1 Virus-Like Particle/AS04 Vaccine
    387. Human Papillomavirus Tumor Antigen Vaccine
    388. Human Papillomavirus Vaccine V503
    389. Human Prostate-Specific Membrane Antigen Plasmid DNA Vaccine
    390. HUVECs-OK432 vaccine
    391. hVEGF26-104/RFASE Peptide Vaccine
    392. HyperAcute - Breast cancer vaccine
    393. HyperAcute-Melanoma Vaccine
    394. HyperAcute-Prostate Cancer Vaccine
    395. ICT-121 Dendritic Cell Vaccine
    396. IDD-3
    397. IDH1R132H Mutation-targeting IDH1 Peptide Vaccine
    398. IDH1R132H-Specific Peptide Vaccine PEPIDH1M
    399. Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020
    400. IDO peptide vaccine
    401. IFN/tremem
    402. IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051
    403. IL-12p70
    404. IL-2, Peptide, and GM-CSF-in-adjuvant Melanoma Vaccine
    405. IL-2/Lptn Gene-Modified Allogeneic Neuroblastoma Tumor Cell Vaccine
    406. IL15-DC Vaccine
    407. IMM-101
    408. Immunotherapeutic GSK1572932A
    409. IMT-1012 Immunotherapeutic Vaccine
    410. Inactivated Vaccinia Virus
    411. Inalimarev Vaccine
    412. Incomplete Freund's adjuvant (IFA) alone, or a melanoma vaccine in IFA
    413. Indium In 111-Labeled Autologous Peripheral Blood Mononuclear Cells Vaccine
    414. Indium In 111-Labeled Autologous Polymorphonuclear Leukocytes Vaccine
    415. Indoleamine 2,3-dioxygenase Peptide Vaccine
    416. Interferon-gamma-expressing Adenovirus Vaccine ASN-002
    417. Interleukin-2 Anti-Idiotype Vaccine
    418. Intracel KLH Vaccine
    419. intralesional bacile Calmette-Guérin (BCG)
    420. intralesional bacile Calmette-Guérin (BCG), DTIC, vincristine
    421. Ipilimumab
    422. Ipilimumab
    423. ipilimumab, vemurafenib
    424. irradiated autologous cells
    425. irradiated melanoma cells plus BCG
    426. α-GalCer-loaded tumor-cell vaccine
    427. KLH and Tumor Lysate Pulsed DC Vaccine
    428. KLH-FITC Vaccine
    429. KLH-id Vaccine
    430. KLH-Lymphoma Ig Vaccine
    431. KLH-pulsed autologous dendritic cell vaccine
    432. KRAS-targeted mRNA vaccine
    433. KSA-KLH Conjugate Vaccine
    434. L612 HuMAb
    435. Lapuleucel-T Vaccine
    436. Large Multivalent Immunogen (LMI) vaccine
    437. Leukemic Apoptotic Corpse-Pulsed Autologous Dendritic Cells Vaccine
    438. Light-Emitting Oncolytic Vaccinia Virus GL-ONC1 Vaccine
    439. Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
    440. Liposomal MUC1/PET-lipid A Vaccine
    441. Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809
    442. Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809 Vaccine
    443. Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
    444. LMP-2:340-349 Peptide Vaccine
    445. LMP-2:419-427 Peptide Vaccine
    446. LMP2A-loaded conventional DC vaccine
    447. Long Peptide Vaccine 7
    448. long-peptide vaccine and mAb
    449. Lung metastasis DNA vaccine pCEP4-MUC1 encoding MUC1
    450. LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine
    451. Lymphoma DNA vaccine VαVβVβ-FrC
    452. mAb PC61 and DC/tumor fusion
    453. MAGE-1 Vaccinia Contaminated with BVDV
    454. MAGE-3.A1 Peptide Vaccine
    455. MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine
    456. MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
    457. MAGE-A12:170-178
    458. MAGE-A3 + AS15
    459. MAGE-A3 Peptide Vaccine
    460. MAGE-A3-expressing Adenovirus Type 5 Vaccine
    461. MAGE-A3-genetically modified lymphocytes
    462. MAGE-A3/HPV 16 Peptide Vaccine
    463. Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
    464. Mammaglobin-A DNA Vaccine
    465. Maraba virus MG1 Vaccine
    466. MART-1
    467. MART-1 Adenovirus Vaccine
    468. MART-1 Fowlpox Vaccine
    469. MART-1 Vaccinia Vaccine
    470. MART-1, tyrosinase and MAGE-A6 Autologous DC Vaccine
    471. MART-1/gp100/Tyrosinase/MAGE-A3 Peptides-loaded Irradiated Allogeneic Plasmacytoid Dendritic Cells Vaccine
    472. MART-1:26-35(27L) Peptide Vaccine
    473. MART-1:27-35 Peptide Vaccine
    474. Mature dendritic cell melanoma vaccine
    475. MCMV-TRP2
    476. mCRT-vGPCR-coated whole-cell vaccine
    477. MDX-1379 (gp100) Melanoma Peptide Vaccine
    478. MDX-CTLA4 Antibody/Tyrosinase/gp100/MART-1 Melanoma Vaccine
    479. Melacine
    480. Melan-A VLP Vaccine
    481. Melan-A/MAGE-3.DP4 Peptide Vaccine
    482. Melan-A/Mart-1
    483. Melanoma DNA vaccine gp75 DNA encoding melanosomal membrane glycoproteins, gp75
    484. Melanoma DNA vaccine hTRP2 encoding TRP-2
    485. Melanoma DNA vaccine hugp100 encoding gp100
    486. Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP
    487. Melanoma DNA vaccine pN4a-MAGE-1-GM
    488. Melanoma DNA vaccine pNL3-MAGE-1-GM
    489. Melanoma DNA vaccine pUB-TRP-2 encoding a fusion protein linking murine ubiquitin (UB) to the N-terminus of the full-length mTRP-2
    490. Melanoma DNA vaccine SINCp c-muMUC18 encoding MCAM/MUC18
    491. Melanoma DNA vaccine TA2Mâ„¢ encoding tyrosinase peptides
    492. Melanoma DNA vaccine VR-S8/VR-IL2/AD-S8 encoding survivin
    493. Melanoma DNA vaccine VR1012/mPmel17
    494. Melanoma DNA vaccine xenogeneic DNA encoding murine tyrosinase
    495. melanoma helper peptide vaccine
    496. Melanoma recombinant vector vaccine rVVmTRP-1 encoding TRP-1
    497. Melanoma Theraccine
    498. Melanoma-specific Melan-A/Mart-1 peptide + virus-like nanoparticles
    499. Melapuldencel-T Vaccine
    500. MELITAC 12.1 Peptide Vaccine
    501. Mesothelioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
    502. Methanol Extraction Residue of BCG
    503. MG1-hDCT Vaccine
    504. MiHA-loaded PD-L1/L2-silenced Dendritic Cell Vaccine
    505. Mimotope-P10s-PADRE Peptide Vaccine
    506. Mixed bacterial vaccine
    507. Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
    508. Modified Vaccinia Virus Ankara Vaccine Expressing p53
    509. Monoclonal Antibody 105AD7 Anti-idiotype Vaccine
    510. Monoclonal Antibody 11D10 Anti-Idiotype Vaccine
    511. Monoclonal Antibody 3H1 Anti-Idiotype Vaccine
    512. Monoclonal Antibody 4B5 Anti-Idiotype Vaccine
    513. Monoclonal Antibody A1G4 Anti-Idiotype Vaccine
    514. Monoclonal Antibody GD2 Anti-Idiotype Vaccine
    515. Montanide ISA-51/Survivin Peptide Vaccine
    516. Mouse gp100 Plasmid DNA Vaccine
    517. Mouse Prostate-Specific Membrane Antigen Plasmid DNA Vaccine
    518. mouse/human gp10025-33 peptide plus CpG adjuvant; mouse/human gp100; mouse/human gp10025-33 peptide-pulsed DCs
    519. MOv-PBL Vaccine
    520. mRNA neoantigen tumor vaccine
    521. mRNA tumor antigen DC vaccine
    522. mRNA-based Personalized Cancer Vaccine NCI-4650
    523. mRNA-Derived Prostate Cancer Vaccine CV9103
    524. mRNA-electroporated dendritic cells encoding gp100 and tyrosinase as melanoma vaccine
    525. MSCV-MGMT(P140K) Vaccine
    526. MT-201-GBM monocyte vaccine
    527. MUC-1 Peptide Vaccine
    528. MUC-2-Globo H-KLH Conjugate Vaccine
    529. MUC-2-KLH Vaccine
    530. MUC1 Antigen/SB AS-2 Vaccine
    531. MUC1 Peptide-Poly-ICLC Vaccine
    532. MUC1-FSL-1-TT tricomponent vaccine
    533. MUC1-KLH Conjugate Vaccine
    534. MUC1-KLH Vaccine/QS21
    535. MUC1-targeted Peptide GO-203-2C Vaccine
    536. Multi-epitope Folate Receptor Alpha Peptide Vaccine
    537. Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
    538. Multi-epitope HER2 Peptide Vaccine TPIV100
    539. Multi-epitope melanoma peptide vaccine
    540. Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
    541. Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
    542. Multiantigen Liposome Loaded Dendritic Cell Vaccine
    543. Multipeptide melanoma vaccine
    544. Multipeptide Vaccine S-588210
    545. Multipeptide XS15 Vaccine
    546. Multiple Signals loaded Dendritic Cells Vaccine
    547. Multivalent immunotherapeutic vaccine
    548. Murine TYRP2 Plasmid DNA Vaccine
    549. Mutant p53 Peptide Pulsed Dendritic Cell Vaccine
    550. Mutated neopeptide vaccine
    551. MVA-BN-CV301
    552. MVA-EBNA1/LMP2 Vaccine
    553. MVA-FCU1 TG4023 Vaccine
    554. MVA-MUC1-IL2 Vaccine
    555. MVA-PSA/PAP Prostate Cancer Vaccine
    556. MVF-HER-2(597-626)/MVF-HER-2 (266-296) Peptide Vaccine
    557. MVF-HER-2(628-647)-CRL 1005 vaccine
    558. NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine
    559. NA17.A2 Peptide Vaccine
    560. Natural Killer Cells ZRx101 Vaccine
    561. Nelipepimut-S Plus GM-CSF Vaccine
    562. NEO-PV-01 vaccine
    563. Neoantigen DNA Vaccine
    564. Neoantigen Peptide Vaccine
    565. neoantigen synthetic long peptide vaccine
    566. Neoantigen-loaded Autologous Dendritic Cell Vaccine
    567. Neuroblastoma DNA vaccine HuDsec
    568. Newcastle disease virus lysate
    569. NY-ESO-1 Peptide Vaccine
    570. NY-ESO-1 Plasmid DNA Cancer Vaccine
    571. NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
    572. NY-ESO-1, MAGE-A1, and MAGE-A3 Dendritic Cell Vaccine
    573. NY-ESO-1/GLA-SE Vaccine ID-G305AmN
    574. NY-ESO-1/LAGE-1 Peptide Vaccine
    575. NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine
    576. NY-ESO-1/PRAME/MAGE-A3/WT-1 Peptide Vaccine
    577. NY-ESO-1b Peptide Vaccine
    578. NY-ESO-B Vaccine
    579. OCDC and NeoDC Vaccine
    580. Oncolytic Adenovirus Encoding GM-CSF Vaccine
    581. Oncovax-ID/IL-2 Vaccine
    582. ONYX-015 Vaccine
    583. Oral Bacille Calmette-Guérin for malignant melanoma
    584. Oral Cancer Vaccine V3-OVA
    585. Oral Therapeutic Vaccine V3-X
    586. OVA-TEXO
    587. Ovapuldencel-T Vaccine
    588. Ovarian Cancer Peptide Vaccine
    589. Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine
    590. Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine
    591. p.DOM-WT1-126 DNA Vaccine
    592. p.DOM-WT1-37 DNA Vaccine
    593. P30-linked EphA2/CMV pp65/Survivin Peptide Vaccine P30-EPS
    594. P501-AS15 vaccine
    595. p53 Peptide Vaccine
    596. P53-Synthetic Long Peptides Vaccine
    597. PA-1-STK Ovarian Carcinoma Vaccine
    598. PADRE-CMV Fusion Peptide Vaccine
    599. Pancreatic tumor personalized neoantigen vaccine
    600. PAX3/FKHR Peptide Vaccine
    601. pcDNA3-MCC/ST
    602. PCLUS 3-18MN Vaccine
    603. PCLUS 6.1-18MN Vaccine
    604. pCR3.1-VS-HSP65-TP-GRP6-M2
    605. PD-L1 peptide vaccine
    606. PD-L1/IDO Peptide Vaccine IO102-103
    607. PEP-3-KLH Conjugate Vaccine
    608. PEP-CMV Vaccine
    609. Personal neoantigen cancer vaccine
    610. Personalized follicular lymphoma vaccine
    611. Personalized mature dendritic cell vaccine
    612. Personalized NeoAntigen Melanoma Vaccine
    613. Personalized Synthetic Long Peptide Breast Cancer Vaccine
    614. Pexastimogene-devacirepvec Vaccine
    615. PF-04948568 Vaccine
    616. Plasmacytoid Dendritic Cell Vaccine
    617. pNGVL3-hICD Vaccine
    618. pNGVL4a-CRT/E7(detox) DNA Vaccine
    619. pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine
    620. Poliovirus vector expressing model antigen H2-Kb-restricted CTL epitope
    621. Poly Microsphere Encapsulated HER2/neu Oral Vaccine
    622. PolyPEPI1018 CRC Vaccine
    623. Polyvalent melanoma vaccine
    624. PR-151 Peptide Vaccine
    625. PR1 Leukemia Peptide Vaccine
    626. Primary Prostate Cancer Tissue/hTERT/Survivin mRNA-loaded Autologous Dendritic Cell Vaccine
    627. prime/boost DC-TRP-2 melanoma vaccine
    628. procarbazine, dactinomycin, velba
    629. Prodencel
    630. Prostate cancer DNA vaccine encoding PSCA
    631. Prostate cancer DNA vaccine hPSMAt encoding PSMA
    632. Prostate cancer DNA vaccine pcDNA3-STEAP encoding six-transmembrane epithelial antigen
    633. Prostate cancer DNA vaccine pDOM-PSMA27 encoding PSMA
    634. Prostate cancer DNA vaccine pmPSCA encoding PSCA
    635. Prostate cancer DNA vaccine PSCA-HSP encoding PSCA and HSP
    636. Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
    637. Prostate cancer DNA vaccine pVax-PSA
    638. Prostate cancer DNA vaccine rPSMAt encoding PSMA
    639. Prostate Cancer Vaccine ONY-P1
    640. Prostate Tumor Antigen-activated Autologous Dendritic Cell Vaccine
    641. PROSTVAC-Contaminated W/ BVDV
    642. PSA Prostate Cancer Vaccine
    643. PSA RNA-Pulsed Dendritic Cell Vaccine
    644. PSA-OP Peptide Vaccine
    645. PSA-PAP/KLH-pulsed Autologous Dendritic Cell Vaccine
    646. PSA/IL-2/GM-CSF Vaccine
    647. PSA/PSMA DNA Plasmid INO-5150 Vaccine
    648. PSA:154-163 Peptide Vaccine
    649. PSA:154-163(155L) Peptide Vaccine
    650. PSMA/TARP Peptide Vaccine
    651. pTVG-HP Plasmid DNA Vaccine
    652. Pulmonary BCG immunotherapy for malignant melanoma
    653. pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine
    654. pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
    655. pVAXrcPSAv53l DNA Vaccine
    656. Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine
    657. Racotumomab Vaccine
    658. RAS Peptide Cancer Vaccine
    659. RAS Peptide Cancer Vaccine TG01
    660. RASVAC-C Vaccine
    661. RASVAC-V Vaccine
    662. RCAS-Akt Vaccine
    663. RCAS-Ras Vaccine
    664. Recombinant Adenovirus 5 Encoding Tumor Necrosis Factor-related Apoptosis-Inducing Ligand Vaccine
    665. Recombinant Adenovirus-Cre Recombinase Vaccine
    666. Recombinant Adenovirus-hIFN-beta Vaccine
    667. Recombinant Adenovirus-Interferon/Syn3 Vaccine
    668. Recombinant Adenovirus-L523S Vaccine
    669. Recombinant Adenovirus-LacZ Vaccine
    670. Recombinant Adenovirus-p53 SCH-58500 Vaccine
    671. Recombinant Anti-WT1 Immunotherapeutic GSK2302024A Vaccine
    672. Recombinant Colorectal cancer antigen GA733 Vaccine
    673. Recombinant dHER2 Vaccine
    674. Recombinant DNA-L523S Vaccine
    675. Recombinant Fowlpox GM-CSF Vaccine Adjuvant
    676. Recombinant Fowlpox-B7.1 Vaccine
    677. Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
    678. Recombinant Fowlpox-gp100p209 Vaccine
    679. Recombinant Fowlpox-Mgp100 Vaccine
    680. Recombinant Fowlpox-Prostate Specific Antigen Vaccine
    681. Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
    682. Recombinant Fowlpox-TRICOM Vaccine
    683. Recombinant Fowlpox-Tyrosinase Vaccine
    684. Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
    685. Recombinant Human Fusion Protein L19TNFalpha Vaccine
    686. Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
    687. Recombinant Human MUC1-Oxidized Polymannose-pulsed Autologous Dendritic Cell Vaccine
    688. Recombinant Human Papillomavirus Nonavalent Vaccine
    689. Recombinant Modified Vaccinia Ankara-5T4 Vaccine
    690. Recombinant NY-ESO-1 ISCOMATRIX Vaccine
    691. Recombinant NY-ESO-1 Protein vaccine adjuvanted with Imiquimod
    692. Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207
    693. Recombinant Vaccinia DF3/MUC1 Vaccine
    694. Recombinant Vaccinia PSA Vaccine
    695. Recombinant Vaccinia Viral Vector RO5217790 Vaccine
    696. Recombinant Vaccinia-CEA Vaccine
    697. Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine
    698. Recombinant Vaccinia-gp100:209-217 Vaccine
    699. Recombinant Vaccinia-Mgp100 Vaccine
    700. Recombinant Vaccinia-MUC-1 Vaccine
    701. Recombinant Vaccinia-MUC1-B7 Vaccine
    702. Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
    703. Recombinant Vaccinia-NY-ESO-1 Vaccine
    704. Recombinant Vaccinia-Prostate Specific Antigen Vaccine
    705. Recombinant Vaccinia-PSA/PSMA Vaccine
    706. Recombinant Vaccinia-TRP1 Vaccine
    707. Remestemcel-L Vaccine
    708. Renal Cell Carcinoma Peptides Vaccine IMA901
    709. Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003
    710. Renal Tumor-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
    711. Retrovector Encoding Mutant Anti-Cyclin G1 Vaccine
    712. Retroviral Vector MFGS-MOv18-gamma Vaccine
    713. rF-MUC1(DF3)/TRICOM Vaccine
    714. rF-PSA/PSMA/TRICOM Vaccine
    715. Rilimogene-galvacirepvec Vaccine
    716. RIPO(H3.3)
    717. rMCMV-TRP2
    718. rMeV- SCD
    719. rMVTT- HPV16-E6/E7
    720. Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant
    721. Sargramostim Plasmid DNA Pancreatic Tumor Cell Vaccine
    722. SCIB1 DNA vaccine
    723. secPD-L1
    724. short overlapping peptides and full-length recombinant protein
    725. Sialyl Lewis-keyhole limpet hemocyanin conjugate vaccine
    726. Sialyl Tn-KLH Vaccine
    727. Sipuleucel-T Vaccine
    728. smallpox vaccine
    729. SRL172
    730. STn-KLH plus Detox Vaccine
    731. Survivin Antigen Vaccine DPX-Survivac
    732. Survivin Sur1M2 Peptide Vaccine
    733. Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine
    734. SVN53-67/M57-KLH Peptide Vaccine
    735. Synchotrope TA2M Vaccine
    736. Synchrotope TA2M Plasmid DNA Vaccine
    737. Synchrovax SEM Plasmid DNA Vaccine
    738. Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine
    739. Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2
    740. Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1
    741. Synthetic hTERT DNA Vaccine INO-1400
    742. Synthetic Long E6/E7 Peptides Vaccine HPV-01
    743. Synthetic Melanoma-Associated Antigens Vaccine
    744. Synthetic MUC1 Peptide Vaccine
    745. Synthetic Peptides E-PRA And E-PSM Vaccine
    746. TARP 27-35 Peptide Vaccine
    747. TARP 29-37-9V Peptide Vaccine
    748. TBC-CEA-Contaminated W/ BVDV Vaccine
    749. Telomerase Peptide Vaccine GV1001
    750. Telomerase-specific Type 5 Adenovirus OBP-301 Vaccine
    751. Telomerase: 540-548 Peptide Vaccine
    752. Tergenpumatucel-L Vaccine
    753. Tetanus peptide melanoma vaccine
    754. Tetravalent RNA-lipoplex Cancer Vaccine
    755. TGFβ2 Antisense-GMCSF Gene Modified Autologous Tumor Cell Vaccine
    756. Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
    757. TICE BCG
    758. TLR-9/GM Vaccine
    759. Tn(c)-KLH Conjugate Vaccine
    760. Total Tumor RNA-loaded Dendritic Cell Vaccine
    761. Transgenic Lymphocyte Immunization Vaccine
    762. TriAd Cancer Vaccine
    763. TriMixDC-MEL Vaccine
    764. TRP-2: 180-188 Peptide Vaccine
    765. TRP1(0RF3):1-9 Peptide Vaccine
    766. Tumor antigen-sensitized DC vaccine
    767. Tumor Cell Derivative Vaccine
    768. Tumor Lysate-pulsed Dendritic Cell Vaccine
    769. Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine
    770. TVI-Brain-1
    771. Tyrosinase-KLH Vaccine
    772. tyrosinase240–251S, 368-376D Vaccine
    773. Unconjugated Lymphoma Ig Id Vaccine
    774. Unconjugated Myeloma Ig Id Vaccine
    775. URLC10 Peptide Vaccine
    776. URLC10-CDCA1-KOC1 Multipeptide Vaccine
    777. URLC10-TTK-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine
    778. UV1 Telomerase Peptide Vaccine
    779. vaccinia melanoma cell lysates (VMCL) Vaccine
    780. Vaccinia Melanoma Oncolysates (VMO) Vaccine
    781. Vaccinia Virus DD-CDSR Vaccine
    782. Vaccinia-GM-CSF Vaccine
    783. Vaccinia-Tyrosinase Vaccine
    784. VCL-CB01 Vaccine
    785. VEGFR-2 DNA Vaccine VXM01
    786. VEGFR1-1084 Peptide Vaccine
    787. VEGFR2-169 Peptide Vaccine
    788. Verpasep Caltespen Vaccine
    789. VHL-42: 65-76(V74G) Peptide Vaccine
    790. VHL-59: 116-128 Peptide Vaccine
    791. VHL14 Peptide Vaccine
    792. VHL16 Peptide Vaccine
    793. VHL2 (Y12M) Peptide Vaccine
    794. Vi Capsular Polysaccharide Typhoid Vaccine
    795. Viagenpumatucel-L Vaccine
    796. VMCL
    797. Von Hippel-Lindau Peptide Vaccine
    798. Whole tumor cell-based leukemia vaccine
    799. WT1 124-138 Peptide Vaccine
    800. WT1 126-134 Peptide Vaccine
    801. WT1 235-243 Peptide Vaccine
    802. WT1 247-261 Peptide Vaccine
    803. WT1 Analog Peptide Vaccine
    804. WT1 Peptide Vaccine OCV-501
    805. WT1 Peptide Vaccine WT2725
    806. WT1 Trio Peptide Vaccine
    807. WT1-A10/AS01B Immunotherapeutic GSK2130579A Vaccine
    808. XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410
    809. Xenogeneic Tyrosinase DNA Vaccine
  4. References
I. General Information
1. Disease:
Cancer
2. Introduction
Cancer is a class of diseases in which a group of cells display uncontrolled growth (division beyond the normal limits), invasion (intrusion on and destruction of adjacent tissues), and sometimes metastasis (spread to other locations in the body via lymph or blood). These three malignant properties of cancers differentiate them from benign tumors, which are self-limited, and do not invade or metastasize. Most cancers form a tumor but some, like leukemia, do not. The branch of medicine concerned with the study, diagnosis, treatment, and prevention of cancer is oncology.

Cancer affects people at all ages with the risk for most types increasing with age. Cancer caused about 13% of all human deaths in 2007 (7.6 million). Cancers are caused by abnormalities in the genetic material of the transformed cells. These abnormalities may be due to the effects of carcinogens, such as tobacco smoke, radiation, chemicals, or infectious agents. Other cancer-promoting genetic abnormalities may randomly occur through errors in DNA replication, or are inherited, and thus present in all cells from birth. The heritability of cancers is usually affected by complex interactions between carcinogens and the host's genome.

Genetic abnormalities found in cancer typically affect two general classes of genes. Cancer-promoting oncogenes are typically activated in cancer cells, giving those cells new properties, such as hyperactive growth and division, protection against programmed cell death, loss of respect for normal tissue boundaries, and the ability to become established in diverse tissue environments. Tumor suppressor genes are then inactivated in cancer cells, resulting in the loss of normal functions in those cells, such as accurate DNA replication, control over the cell cycle, orientation and adhesion within tissues, and interaction with protective cells of the immune system.

Definitive diagnosis requires the histologic examination of a biopsy specimen, although the initial indication of malignancy can be symptomatic or radiographic imaging abnormalities. Most cancers can be treated and some forced into remission, depending on the specific type, location, and stage. Once diagnosed, cancer is usually treated with a combination of surgery, chemotherapy and radiotherapy. As research develops, treatments are becoming more specific for different varieties of cancer. There has been significant progress in the development of targeted therapy drugs that act specifically on detectable molecular abnormalities in certain tumors, and which minimize damage to normal cells. The prognosis of cancer patients is most influenced by the type of cancer, as well as the stage, or extent of the disease. In addition, histologic grading and the presence of specific molecular markers can also be useful in establishing prognosis, as well as in determining individual treatments (Wiki: Cancer).
Loading...
Loading Pathogen Genes...
Loading...
Loading Host Genes...
Loading...
Loading Vaccines...
Loading References...